Source:http://linkedlifedata.com/resource/pubmed/id/21523634
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:dateCreated |
2011-4-27
|
pubmed:abstractText |
Paragangliomas are rare tumors of neural crest origin. They are benign in the majority of cases and are characterized by a strong vascularisation. In the head and neck region they most commonly occur as carotid body tumors. Jugulotympanic and especially vagal paragangliomas are seen less frequently. Complete surgical resection represents the only curative treatment option even though resection of locally advanced tumors regularly results in lesions of the lower cranial nerves and major vessels. Approximately 30% of all head and neck paragangliomas (HNPs) are hereditary and associated with different tumor syndromes. The paraganglioma syndromes 1, 3 and 4 (PGL 1, 3 and 4) make up the majority of those familial cases. PGL 1 is associated with mutations of the succinate dehydrogenase subunit D (SDHD) gene, PGL 3 is caused by SDHC and PGL 4 by SDHB gene mutations. Multiple HNPs and the occurrence of HNPs together with pheochromocytomas are seen in SDHD as well as SDHB mutation carriers. In patients with SDHB mutations the risk for the development of malignant paraganglial tumors is significantly higher compared to SDHC and SDHD patients as well as patients with sporadic tumors. SDHC mutation carriers almost exclusively present with benign HNPs that are unifocal in the majority of cases. The role of transmission is autosomal dominant for all 3 symptoms. Interestingly, there is a "parent-of-origin-dependent-inheritance" in subjects with SDHD gene mutations. This means that the disease phenotype may only become present if the mutation is inherited through the paternal line. We recommend screening for mutations of the genes SDHB, SDHC and SDHD in all patients with HNPs. Certain clinical parameters can help to set up the order in which the 3 genes should be tested.
|
pubmed:language |
ger
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/SDHB protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/SDHC protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/SDHD protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Succinate Dehydrogenase
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1438-8685
|
pubmed:author | |
pubmed:copyrightInfo |
© Georg Thieme Verlag KG Stuttgart · New York.
|
pubmed:issnType |
Electronic
|
pubmed:volume |
90 Suppl 1
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
S56-82
|
pubmed:meshHeading |
pubmed-meshheading:21523634-Chromosome Aberrations,
pubmed-meshheading:21523634-DNA Mutational Analysis,
pubmed-meshheading:21523634-Female,
pubmed-meshheading:21523634-Genetic Predisposition to Disease,
pubmed-meshheading:21523634-Genetic Testing,
pubmed-meshheading:21523634-Heterozygote Detection,
pubmed-meshheading:21523634-Humans,
pubmed-meshheading:21523634-Male,
pubmed-meshheading:21523634-Membrane Proteins,
pubmed-meshheading:21523634-Otorhinolaryngologic Neoplasms,
pubmed-meshheading:21523634-Paraganglioma,
pubmed-meshheading:21523634-Phenotype,
pubmed-meshheading:21523634-Sex Chromosome Aberrations,
pubmed-meshheading:21523634-Succinate Dehydrogenase,
pubmed-meshheading:21523634-Syndrome
|
pubmed:year |
2011
|
pubmed:articleTitle |
[Paragangliomas and paraganglioma syndromes].
|
pubmed:affiliation |
Universitätsklinik für Hals-, Nasen- und Ohrenheilkunde und Poliklinik, Freiburg, Germany. carsten.boedeker@uniklinik-freiburg.de
|
pubmed:publicationType |
Journal Article,
English Abstract,
Review
|